STOCK TITAN

Medline Inc. (NASDAQ: MDLN) director reports zero beneficial share ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Medline Inc. director Robert R. Schmidt filed an initial insider ownership report in connection with an event dated 12/17/2025. This filing states that he currently has no securities beneficially owned in Medline Inc., meaning he does not report owning any Medline common stock or derivative securities at this time. The form is filed by a single reporting person and reflects his status solely as a director, not as an officer or 10% owner.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Schmidt Robert R.

(Last) (First) (Middle)
C/O MEDLINE INC.
3 LAKES DRIVE

(Street)
NORTHFIELD IL 60093

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/17/2025
3. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Robert R. Schmidt 01/08/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Medline Inc. (MDLN) disclose in this Form 3 filing?

The filing shows that director Robert R. Schmidt reports no beneficial ownership of Medline Inc. securities as of an event dated 12/17/2025.

Who is the reporting person in this Medline Inc. (MDLN) insider ownership report?

The reporting person is Robert R. Schmidt, who is identified as a director of Medline Inc. and not as an officer or 10% owner.

Does Robert R. Schmidt own any Medline Inc. (MDLN) shares according to this Form 3?

No. The explanation of responses clearly states that no securities are beneficially owned by the reporting person.

Are there any transactions reported in this Medline Inc. (MDLN) Form 3?

No transactions are listed. The tables for non-derivative and derivative securities show no holdings, consistent with the statement that no securities are beneficially owned.

What is the date of the event requiring this Medline Inc. (MDLN) Form 3?

The date of the event requiring this statement is 12/17/2025, as indicated in the filing.

Is this Medline Inc. (MDLN) Form 3 filed by more than one reporting person?

No. The filing indicates that it is a Form filed by one reporting person, namely director Robert R. Schmidt.

MEDLINE INC

NASDAQ:MDLN

MDLN Rankings

MDLN Latest News

MDLN Latest SEC Filings

MDLN Stock Data

37.69B
216.03M